Single, Ascending Dose, First Time in Human Study for GZR18 in Healthy Subjects

NCT05328726 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: GZR-18
OTHER: Placebo

Sponsor

Gan and Lee Pharmaceuticals, USA